Seres Therapeutics IPO Research Information

Seres Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Seres Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Seres Therapeutics	MCRB - NASDAQ	$15.00-$17.00	$18.00	$28.50	7.43 million	6/26/2015
Underwriter(s): Goldman Sachs & Co., BofA Merrill Lynch
Co-Manager(s): Leerink Partners, Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2015-05-27 Terms Added 2015-06-16

Seres Therapeutics Quote & Chart - Click for current quote - MCRB

About Seres Therapeutics (adapted from Seres Therapeutics prospectus):
They are a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MCRB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.